Inhibrx Biosciences, Inc.
USD95.22
+1.59 (+1.70%)
CEO
Mark Paul Lappe
IPO Date
2024-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$93.31
Prev. Close
$93.63
Day Low
$90.88
Day High
$96.16
52W Low
$12.80
52W High
$155.29
Market Cap
$1.40B
Volume
0.33M
| 22 Jan 2025 | JMP Securities | Market Perform | Market Perform | maintain |
| 23 Jan 2024 | JMP Securities | Market Outperform | Market Perform | downgrade |
| 20 Nov 2023 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 23 Aug 2023 | JMP Securities | Outperform | Outperform | maintain |
| 10 May 2023 | JMP Securities | Market Outperform | Outperform | maintain |
| 8 Mar 2023 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 7 Mar 2023 | Credit Suisse | Outperform | Outperform | maintain |